Jerold Chun

Q: What Schools Are Affiliated With Jerold Chun

Jerold Chun is affiliated with the following schools: Hokkaido University, University of Kentucky, California Institute of Technology, University of British Columbia, University of California, San Diego, Sanford Burnham Prebys Medical Discovery Institute, Massachusetts Institute of Technology, Stanford University

Jerold Chun's AcademicInfluence.com Rankings

Jerold Chun

Biology

#6395

World Rank

#9097

Historical Rank

Neuroscience

#775

World Rank

#808

Historical Rank

Biochemistry

#810

World Rank

#916

Historical Rank

biology Degrees

Download Badge

Biology

Jerold Chun's Degrees

PhD Neuroscience Stanford University

Why Is Jerold Chun Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jerold Chun's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

LPA receptors: subtypes and biological actions. (2010) (776)
Lysophospholipid receptors: signaling and biology. (2004) (767)
Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex (1996) (731)
Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain (2016) (706)
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. (2004) (687)
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak (2008) (679)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis (2010) (668)
Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain (2017) (629)
Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate* (2004) (593)
Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. (1996) (538)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation (2010) (533)
LPA receptor signaling: pharmacology, physiology, and pathophysiology (2014) (505)
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing (2005) (495)
Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. (2000) (486)
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature (2002) (482)
GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5* (2006) (461)
E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas (1997) (428)
Lysophosphatidic acid receptors. (2000) (410)
Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function (2003) (404)
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor (2006) (374)
Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis (2011) (368)
Sphingosine Kinase Type 2 Is a Putative BH3-only Protein That Induces Apoptosis* (2003) (358)
Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. (2010) (341)
Chromosomal variation in neurons of the developing and adult mammalian nervous system (2001) (326)
Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2 (2002) (321)
Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis (2015) (320)
Constitutional Aneuploidy in the Normal Human Brain (2005) (320)
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature (2010) (319)
Transient cells of the developing mammalian telencephalon are peptide-immunoreactive neurons (1987) (318)
T-bet–dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow (2009) (310)
Identification of a Novel Protein Kinase A Anchoring Protein That Binds Both Type I and Type II Regulatory Subunits* (1997) (299)
Lysophospholipid G Protein-coupled Receptors* (2004) (293)
Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3* (2001) (286)
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling (2004) (285)
A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. (1998) (281)
Dendritic cell PAR1–S1P3 signalling couples coagulation and inflammation (2008) (281)
Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1* (2004) (280)
The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system (1991) (280)
Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. (1999) (264)
Interstitial cells of the adult neocortical white matter are the remnant of the early generated subplate neuron population (1989) (262)
Lysophospholipid receptor nomenclature review: IUPHAR Review 8 (2014) (261)
Marked Perinatal Lethality and Cellular Signaling Deficits in Mice Null for the Two Sphingosine 1-Phosphate (S1P) Receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3* (2002) (257)
Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking. (1991) (257)
Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding (2003) (254)
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy (2013) (252)
Emerging medicinal roles for lysophospholipid signaling. (2006) (248)
Lysophosphatidic acid (LPA) and its receptors. (2009) (244)
Programmed cell death is a universal feature of embryonic and postnatal neuroproliferative regions throughout the central nervous system (1998) (238)
A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1. (1997) (237)
D-AKAP2, a novel protein kinase A anchoring protein with a putative RGS domain. (1997) (237)
Sphingosine 1-phosphate receptor agonists attenuate relapsing–remitting experimental autoimmune encephalitis in SJL mice (2004) (234)
Lysophospholipids and their receptors in the central nervous system. (2013) (230)
Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. (2000) (225)
Cell surface receptors in lysophospholipid signaling. (2004) (222)
Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells (2013) (218)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors (2021) (212)
Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. (2007) (211)
Lysophosphatidic Acid Signaling in the Nervous System (2015) (209)
The Role of the Subplate in the Development of the Mammalian Telencephalon (1988) (203)
Lysophospholipid receptors. (2001) (200)
Defective embryonic neurogenesis in Ku-deficient but not DNA-dependent protein kinase catalytic subunit-deficient mice. (2000) (199)
LPA1 receptor activation promotes renal interstitial fibrosis. (2007) (198)
A multimodal cell census and atlas of the mammalian primary motor cortex (2020) (190)
Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. (2011) (188)
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor (2006) (184)
Lysophosphatidic acid receptor gene vzg‐1/lpA1/edg‐2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain (1998) (184)
Sphingosine 1-Phosphate ( S 1 P ) Receptor Subtypes S 1 P 1 and S 1 P 3 , Respectively , Regulate Lymphocyte Recirculation and Heart Rate * (2004) (181)
Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression (2006) (179)
Comparative cellular analysis of motor cortex in human, marmoset and mouse (2021) (177)
Regulation of Schwann Cell Morphology and Adhesion by Receptor-Mediated Lysophosphatidic Acid Signaling (2001) (177)
Aneuploid neurons are functionally active and integrated into brain circuitry (2005) (175)
A comparative strategy for single-nucleus and single-cell transcriptomes confirms accuracy in predicted cell-type expression from nuclear RNA (2017) (173)
A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya). (2011) (171)
Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. (2000) (165)
Novel Dendritic Kinesin Sorting Identified by Different Process Targeting of Two Related Kinesins: KIF21A and KIF21B (1999) (163)
LPA4/GPR23 Is a Lysophosphatidic Acid (LPA) Receptor Utilizing Gs-, Gq/Gi-mediated Calcium Signaling and G12/13-mediated Rho Activation* (2007) (160)
Lysophospholipid receptors in drug discovery. (2015) (159)
Somatic APP gene recombination in Alzheimer’s disease and normal neurons (2018) (156)
Sphingosine Kinase Type 1 Induces G12/13-mediated Stress Fiber Formation, yet Promotes Growth and Survival Independent of G Protein-coupled Receptors* (2003) (156)
Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. (2011) (156)
Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1 (2015) (154)
Lysophosphatidic Acid Inhibits Adipocyte Differentiation via Lysophosphatidic Acid 1 Receptor-dependent Down-regulation of Peroxisome Proliferator-activated Receptor γ2* (2005) (153)
Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts (2014) (152)
Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. (1999) (148)
A fibronectin-like molecule is present in the developing cat cerebral cortex and is correlated with subplate neurons (1988) (146)
The S1P2 Receptor Negatively Regulates Platelet-Derived Growth Factor-Induced Motility and Proliferation (2005) (144)
HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase–Dependent Monocyte Chemoattractant Protein-1 Production (2008) (144)
Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. (2008) (143)
Lysophosphatidic Acid Influences the Morphology and Motility of Young, Postmitotic Cortical Neurons (2002) (143)
Absence of LPA1 signaling results in defective cortical development. (2008) (142)
Lysophosphatidic acid as a novel cell survival/apoptotic factor. (2002) (141)
Apoptotic DNA fragmentation is detected by a semi-quantitative ligation-mediated PCR of blunt DNA ends (1997) (137)
The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer. (2009) (136)
Analysis of sphingosine 1‐phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools (2008) (136)
Chromosome Segregation Defects Contribute to Aneuploidy in Normal Neural Progenitor Cells (2003) (136)
Insights into the pharmacological relevance of lysophospholipid receptors (2012) (135)
S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. (2005) (135)
Lysophosphatidic Acid Signaling May Initiate Fetal Hydrocephalus (2011) (135)
Immunomodulator FTY720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S1P3 (2005) (132)
Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury. (2010) (132)
LPA1‐induced cytoskeleton reorganization drives fibrosis through CTGF‐dependent fibroblast proliferation (2013) (127)
S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. (2010) (126)
The LPA receptors. (2001) (122)
Alteration of Gene Expression by Chromosome Loss in the Postnatal Mouse Brain (2003) (118)
Sphingosine 1-Phosphate (S1P) Signaling Is Required for Maintenance of Hair Cells Mainly via Activation of S1P2 (2007) (115)
Expression and Function of Lysophosphatidic Acid Receptors in Cultured Rodent Microglial Cells* (2001) (115)
Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus (2008) (114)
New developments in the biological functions of lysophospholipids (2006) (112)
Targeted Deletion of LPA5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of Neuropathic Pain* (2012) (111)
Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains (2015) (111)
Lysophosphatidic acid signalling in development (2015) (109)
Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. (2013) (106)
High-Density Lipoprotein Stimulates Myocardial Perfusion In Vivo (2004) (106)
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain (2008) (106)
In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. (2002) (105)
Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p1 in neurogenesis and s1p1–3 in angiogenesis (2002) (105)
Synaptic PRG-1 Modulates Excitatory Transmission via Lipid Phosphate-Mediated Signaling (2009) (103)
Redistribution of synaptic vesicle antigens is correlated with the disappearance of a transient synaptic zone in the developing cerebral cortex (1988) (102)
The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury. (2012) (101)
Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid (2008) (99)
Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2. (2010) (99)
Embryo Spacing and Implantation Timing Are Differentially Regulated by LPA3-Mediated Lysophosphatidic Acid Signaling in Mice1 (2007) (98)
S1P3‐mediated Akt activation and crosstalk with platelet‐derived growth factor receptor (PDGFR) (2004) (98)
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. (2007) (98)
Lysophosphatidic acid (LPA) signaling in vertebrate reproduction (2010) (97)
Decreased apoptosis in proliferative and postmitotic regions of the caspase 3‐deficient embryonic central nervous system (2000) (97)
Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes (2003) (97)
Lysophosphatidic Acid Receptors 1 and 2 Play Roles in Regulation of Vascular Injury Responses but Not Blood Pressure (2008) (97)
Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling (2015) (95)
Aneuploidy in the normal and diseased brain (2006) (94)
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators (2011) (92)
Neuronal DNA content variation (DCV) with regional and individual differences in the human brain (2010) (92)
Genomic characterization of the lysophosphatidic acid receptor gene, lp(A2)/Edg4, and identification of a frameshift mutation in a previously characterized cDNA. (2000) (88)
Lysophosphatidic Acid Receptor-dependent Secondary Effects via Astrocytes Promote Neuronal Differentiation* (2008) (87)
Glypican‐4 is an FGF2‐binding heparan sulfate proteoglycan expressed in neural precursor cells (2000) (87)
Aneuploid mosaicism in the developing and adult cerebellar cortex (2008) (87)
The sphingosine 1‐phosphate receptor S1P2 triggers hepatic wound healing (2007) (84)
The Sphingosine-1-Phosphate (S1P) Lysophospholipid Receptor S1P3 Regulates MAdCAM-1+ Endothelial Cells in Splenic Marginal Sinus Organization (2004) (84)
Age-Dependent Loss of Sperm Production in Mice via Impaired Lysophosphatidic Acid Signaling1 (2008) (83)
Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury (2015) (82)
Lysophosphatidic Acid Stimulates Neurotransmitter-Like Conductance Changes that Precede GABA and l-Glutamate in Early, Presumptive Cortical Neuroblasts (1999) (82)
Lysophospholipid receptors: implications for neural signaling. (1999) (81)
The genomically mosaic brain: aneuploidy and more in neural diversity and disease. (2013) (80)
S1P1 Receptor Localization Confers Selectivity for Gi-mediated cAMP and Contractile Responses* (2008) (78)
Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor (2010) (78)
Behavioral phenotype of maLPA1‐null mice: increased anxiety‐like behavior and spatial memory deficits (2009) (78)
Rearranging Views on Neurogenesis Neuronal Death in the Absence of DNA End-Joining Proteins (1999) (78)
Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases. (2006) (77)
Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine (2010) (76)
Lysophosphatidic acid in neural signaling. (2002) (75)
The mouse lp(A3)/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern. (2001) (74)
Aggravation of Chronic Stress Effects on Hippocampal Neurogenesis and Spatial Memory in LPA1 Receptor Knockout Mice (2011) (74)
Lysophosphatidic acid stimulates neuronal differentiation of cortical neuroblasts through the LPA1–Gi/o pathway (2007) (74)
Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice. (2013) (74)
LPA3 receptor mediates chemotaxis of immature murine dendritic cells to unsaturated lysophosphatidic acid (LPA) (2007) (73)
Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes (2017) (73)
Failed Clearance of Aneuploid Embryonic Neural Progenitor Cells Leads to Excess Aneuploidy in the Atm-Deficient But Not the Trp53-Deficient Adult Cerebral Cortex (2004) (72)
Genomic mosaicism in the developing and adult brain (2018) (72)
Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma (2009) (71)
Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain (2009) (71)
Necessity of lysophosphatidic acid receptor 1 for development of arthritis. (2013) (67)
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders. (2019) (67)
Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. (2011) (66)
Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells* (2005) (66)
Clonal Cell Lines Produced by Infection of Neocortical Neuroblasts Using Multiple Oncogenes Transduced by Retroviruses (1996) (66)
Evolution of cellular diversity in primary motor cortex of human, marmoset monkey, and mouse (2020) (66)
Normal Human Pluripotent Stem Cell Lines Exhibit Pervasive Mosaic Aneuploidy (2011) (66)
Dual regulation of actin rearrangement through lysophosphatidic acid receptor in neuroblast cell lines: actin depolymerization by Ca(2+)-alpha-actinin and polymerization by rho. (2002) (62)
Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs. (2011) (62)
Lysophosphatidic acid in vascular development and disease (2009) (61)
E2A Deﬁciency Leads to Abnormalities in ab T-Cell Development and to Rapid Development of T-Cell Lymphomas (1997) (60)
Lysophosphatidic acid (LPA) and its receptor, LPA1, influence embryonic schwann cell migration, myelination, and cell‐to‐axon segregation (2013) (60)
Complete cDNA sequence, genomic structure, and chromosomal localization of the LPA receptor gene, lpA1/vzg-1/Gpcr26. (1998) (59)
Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling (2011) (57)
Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (Fingolimod) in multiple sclerosis (2010) (57)
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects (2020) (56)
Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P3 in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone (2009) (56)
Aneuploid Cells Are Differentially Susceptible to Caspase-Mediated Death during Embryonic Cerebral Cortical Development (2012) (55)
An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model (2013) (55)
The absence of LPA receptor 2 reduces the tumorigenesis by ApcMin mutation in the intestine. (2010) (55)
Gradients of the signaling lipid S1P in lymph nodes position natural killer cells and regulate their interferon-γ response (2016) (55)
Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock. (2016) (54)
Lysophospholipids in the nervous system. (2005) (52)
Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells. (2010) (52)
A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs) (2007) (50)
Distinct Phospholipase C-β Isozymes Mediate Lysophosphatidic Acid Receptor 1 Effects on Intestinal Epithelial Homeostasis and Wound Closure (2013) (50)
Diversity of Lysophosphatidic Acid Receptor-Mediated Intracellular Calcium Signaling in Early Cortical Neurogenesis (2010) (49)
Lysophosphatidic acid stimulates astrocyte proliferation through LPA1 (2008) (49)
Hippocampal c-Fos activation in normal and LPA1-null mice after two object recognition tasks with different memory demands (2012) (49)
Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia (2018) (48)
GPR 92 as a New G 12 / 13-and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP , LPA 5 * (2006) (47)
Glycerol-3-phosphate is a FGF23 regulator derived from the injured kidney. (2020) (47)
Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor. (2017) (47)
Neurobiology of Receptor‐Mediated Lysophospholipid Signaling: From the First Lysophospholipid Receptor to Roles in Nervous System Function and Development (2000) (46)
LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage (2015) (44)
Fear extinction and acute stress reactivity reveal a role of LPA1 receptor in regulating emotional-like behaviors (2014) (44)
Altered Spatiotemporal Expression of Collagen Types I, III, IV, and VI in Lpar3-Deficient Peri-Implantation Mouse Uterus1 (2011) (43)
Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy (2016) (43)
Lysophospholipid activation of G protein-coupled receptors. (2008) (43)
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis (2017) (43)
Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling (2015) (42)
Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke. (2020) (42)
Png‐1, a nervous system‐specific zinc finger gene, identifies regions containing postmitotic neurons during mammalian embryonic development (1997) (42)
Sphingosine‐1‐Phosphate Receptor 1 Regulates Cardiac Function by Modulating Ca2+ Sensitivity and Na+/H+ Exchange and Mediates Protection by Ischemic Preconditioning (2016) (42)
Lysophosphatidic Acid Receptor Type 1 (LPA1) Plays a Functional Role in Osteoclast Differentiation and Bone Resorption Activity* (2014) (42)
Involvement of LPA1 receptor signaling in the reorganization of spinal input through Abeta-fibers in mice with partial sciatic nerve injury (2008) (40)
Calpain‐mediated down‐regulation of myelin‐associated glycoprotein in lysophosphatidic acid‐induced neuropathic pain (2010) (40)
A Functionally Defined In Vivo Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes (ieAstrocytes) (2018) (40)
Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain (2006) (39)
Chronic Immobilization in the malpar1 Knockout Mice Increases Oxidative Stress in the Hippocampus (2012) (38)
Numerical chromosome variation and mitotic segregation defects in the adult brain of teleost fish (2007) (38)
S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells. (2011) (38)
Two Novel Xenopus Homologs of Mammalian LPA1/EDG-2 Function as Lysophosphatidic Acid Receptors inXenopus Oocytes and Mammalian Cells* (2001) (37)
The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis. (2018) (37)
Sphingosine 1-phosphate receptor-1 in cardiomyocytes is required for normal cardiac development. (2016) (37)
Involvement of LPA1 receptor signaling in cerebral ischemia-induced neuropathic pain (2013) (36)
Blockade of Sphingosine 1-Phosphate Receptor 2 Signaling Attenuates High-Fat Diet-Induced Adipocyte Hypertrophy and Systemic Glucose Intolerance in Mice. (2016) (36)
Lysophospholipid Receptors: Signaling and Biochemistry (2013) (35)
Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex (2015) (35)
Frequent spontaneous seizures followed by spatial working memory/anxiety deficits in mice lacking sphingosine 1-phosphate receptor 2 (2011) (35)
Growth factor pre-treatment differentially regulates phosphoinositide turnover downstream of lysophospholipid receptor and metabotropic glutamate receptors in cultured rat cerebrocortical astrocytes (2004) (34)
Autotaxin–lysophosphatidic acid–LPA 3 signaling at the embryo‐epithelial boundary controls decidualization pathways (2017) (33)
Unique uterine localization and regulation may differentiate LPA3 from other lysophospholipid receptors for its role in embryo implantation. (2011) (33)
Roles for lysophospholipid S1P receptors in multiple sclerosis (2011) (32)
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models (2015) (32)
Sphingosine 1-phosphate S 1 P 2 and S 1 P 3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury (2007) (32)
Lysophosphatidic Acid Signaling Protects Pulmonary Vasculature From Hypoxia-Induced Remodeling (2012) (32)
Submegabase copy number variations arise during cerebral cortical neurogenesis as revealed by single-cell whole-genome sequencing (2018) (32)
maLPA1-null mice as an endophenotype of anxious depression (2017) (31)
Anandamide‐induced neuroblastoma cell rounding via the CB1 cannabinoid receptors (2002) (31)
TNF-α promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines[S] (2011) (30)
Genetics and cell biology of lysophosphatidic acid receptor‐mediated signaling during cortical neurogenesis (2004) (29)
Selective coupling of the S1P3 receptor subtype to S1P-mediated RhoA activation and cardioprotection. (2017) (29)
LPA1, LPA2, LPA4, and LPA6 receptor expression during mouse brain development (2019) (29)
Synaptic PRG-1 Modulates Excitatory Transmission via Lipid Phosphate-Mediated Signaling (2011) (28)
Lysophosphatidic acid stimulates astrocyte proliferation through LPA1 (2007) (28)
Molecular mechanism of lysophosphatidic acid-induced hypertensive response (2019) (28)
'Crystal' Clear? Lysophospholipid Receptor Structure Insights and Controversies. (2018) (28)
Developmental neurobiology: Alternative ends for a familiar story? (1999) (27)
Maternally Derived Immunoglobulin Light Chain Is Present in the Fetal Mammalian CNS (1997) (26)
LPA1/3 overactivation induces neonatal posthemorrhagic hydrocephalus through ependymal loss and ciliary dysfunction (2019) (26)
Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice (2019) (26)
Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs (2016) (24)
Sphingosine 1-Phosphate Receptors Are Essential Mediators of Eyelid Closure during Embryonic Development* (2013) (24)
Expanded Polyglutamine Domain Proteins Bind Neurofilament and Alter the Neurofilament Network (1999) (23)
V(D)J recombination and the transgenic brain blues. (1992) (23)
Selected comparison of immune and nervous system development. (2001) (22)
Lysophosphatidic Acid Signaling through the Lysophosphatidic Acid-1 Receptor Is Required for Alveolarization. (2016) (22)
Immunomodulator FTY 720 Induces eNOS-Dependent Arterial Vasodilatation via the Lysophospholipid Receptor S 1 P 3 (2005) (22)
Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes (2021) (22)
CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation (2017) (21)
Onset of apoptotic DNA fragmentation can precede cell elimination by days in the small intestinal villus (1998) (20)
Genetic and Functional Evidence Supports LPAR1 as a Susceptibility Gene for Hypertension (2015) (20)
ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation (2016) (20)
Apoptosis detection and assay methods (1998) (19)
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR 4-Dependent Signaling Pathway via the S 1 P 3 Receptor (2006) (19)
LPA1 receptor–mediated thromboxane A2 release is responsible for lysophosphatidic acid‐induced vascular smooth muscle contraction (2017) (19)
Matricellular Protein Cyr61 Bridges Lysophosphatidic Acid and Integrin Pathways Leading to Cell Migration* (2013) (18)
Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain (2015) (18)
Lysophosphatidic acid and its receptor LPA1 mediate carrageenan induced inflammatory pain in mice (2018) (18)
Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry[S] (2018) (18)
Tandem genomic arrangement of a G protein (Gna15) and G protein‐coupled receptor (s1p4 /lpC1 /Edg6) gene (2002) (18)
LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesis (2021) (17)
Progesterone receptor-mediated up-regulation of transthyretin in preimplantation mouse uterus. (2010) (17)
Mathematical modeling supports substantial mouse neural progenitor cell death (2009) (17)
Intravenous Sphingosylphosphorylcholine Protects Ischemic and Postischemic Myocardial Tissue in a Mouse Model of Myocardial Ischemia/Reperfusion Injury (2011) (17)
A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration. (2019) (17)
Altered cell and RNA isoform diversity in aging Down syndrome brains (2021) (17)
Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate (2022) (16)
Developmental neurobiology: A genetic Cheshire cat? (1999) (16)
Immunomodulator FTY 720 Induces Myofibroblast Differentiation via the Lysophospholipid Receptor S 1 P 3 and Smad 3 Signaling (2006) (16)
Effects of genetic deletion versus pharmacological blockade of the LPA1 receptor on depression-like behaviour and related brain functional activity (2018) (15)
Brain cell somatic gene recombination and its phylogenetic foundations (2020) (15)
11-deoxy prostaglandin F(2α), a thromboxane A2 receptor agonist, partially alleviates embryo crowding in Lpar3((-/-)) females. (2012) (15)
Book Review: Neurobiology of Lysophosphatidic Acid Signaling (2002) (15)
Neurobiology of lysophosphatidic acid signaling. (2002) (14)
Lysophospholipid receptors LPA1-3 are not required for the inhibitory effects of LPA on mouse retinal growth cones. (2010) (14)
LPA 3-mediated lysophosphatidic acid signalling in implantation and embryo spacing (2008) (14)
Reduced wheel running and blunted effects of voluntary exercise in LPA1-null mice: The importance of assessing the amount of running in transgenic mice studies (2013) (14)
Chromosomal mosaicism in neural stem cells. (2008) (14)
Cell death, DNA breaks and possible rearrangements: an alternative view (2000) (13)
The Sources of a Lipid Conundrum (2007) (13)
Synaptic Phospholipid Signaling Modulates Axon Outgrowth via Glutamate-dependent Ca2+-mediated Molecular Pathways (2016) (12)
A new method of embryonic culture for assessing global changes in brain organization (2006) (12)
Protective Role for LPA3 in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol (2017) (12)
Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis (2019) (12)
Abrogation of lysophosphatidic acid receptor 1 ameliorates murine vasculitis (2019) (11)
Identification of Neural Programmed Cell Death Through the Detection of DNA Fragmentation In Situ and by PCR (1997) (11)
Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain (2020) (11)
Unlabeled lysophosphatidic acid receptor binding in free solution as determined by a compensated interferometric reader (2020) (11)
Mosaic Somatic Gene Recombination as a Potentially Unifying Hypothesis for Alzheimer’s Disease (2020) (11)
Sphingosine 1-phosphate-mediated α1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions. (2012) (11)
Effects of the LPA1 Receptor Deficiency and Stress on the Hippocampal LPA Species in Mice (2019) (10)
CB1 and LPA1 Receptors Relationship in the Mouse Central Nervous System (2019) (10)
Corrigendum to: “The mouse lpA3/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern” [Gene 267 (2001) 243–253] (2001) (10)
Is a Lysophosphatidic Acid ( LPA ) Receptor Utilizing Gs-, Gq / Gi-mediated Calcium Signaling and G 12 / 13-mediated Rho Activation * (2007) (9)
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. (2019) (9)
Genomic Mosaicism Formed by Somatic Variation in the Aging and Diseased Brain (2021) (9)
Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification. (2020) (9)
LPA3-mediated lysophosphatidic acid signaling promotes postnatal heart regeneration in mice (2020) (9)
Lysophosphatidic acid‐induced c‐fos up‐regulation involves cyclic AMP response element‐binding protein activated by mitogen‐ and stress‐activated protein kinase‐1 (2008) (8)
Exogenous S 1 P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S 1 P Receptor Signaling (2015) (8)
Ser 18 and 23 phosphorylation is required for p 53-dependent apoptosis and tumor suppression (2013) (8)
Lysophosphatidic Acid (LPA) Receptor Signaling (2013) (7)
ERRATUM: Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling (2004) (7)
Chronic central modulation of LPA/LPA receptors-signaling pathway in the mouse brain regulates cognition, emotion, and hippocampal neurogenesis (2020) (6)
Ponesimod inhibits astrocyte‐mediated neuroinflammation and protects against cingulum demyelination via S1P1‐selective modulation (2022) (6)
Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis (2021) (6)
Reply to: APP gene copy number changes reflect exogenous contamination (2020) (6)
Mosaic APP Gene Recombination in Alzheimer’s Disease—What’s Next? (2019) (6)
Pain-like behavior in the collagen antibody-induced arthritis model is regulated by lysophosphatidic acid and activation of satellite glia cells (2022) (6)
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis (2022) (6)
Identification of Neural Programmed Cell Death Through the Detection of DNA Fragmentation In Situ and by PCR (2009) (6)
Correction: Aggravation of Chronic Stress Effects on Hippocampal Neurogenesis and Spatial Memory in LPA1 Receptor Knockout Mice (2011) (5)
Retraction for Gon et al., S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF (2009) (5)
Potential therapeutic roles of lysophospholipid signaling in autoimmune-related disease (2007) (5)
A Soluble Epoxide Hydrolase Inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis (2021) (5)
TNF-promotes LPA 1-and LPA 3-mediated recruitment of leukocytes in vivo through CXCR 2 ligand chemokines (5)
Activation of the ATX/LPA/LPARs axis induces a fibrotic response in skeletal muscle. (2022) (5)
S1P2-Gα12 Signaling Controls Astrocytic Glutamate Uptake and Mitochondrial Oxygen Consumption (2021) (4)
The first cloned and identified lysophospholipid (LP) receptor gene, vzg-1: implications for related receptors and the nervous system. (1999) (4)
Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia (2017) (4)
Reply: Evidence that APP gene copy number changes reflect recombinant vector contamination (2019) (4)
Lysophosphatidic Acid Receptor 3 Suppress Neutrophil Extracellular Traps Production and Thrombosis During Sepsis (2022) (4)
Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex (2014) (4)
HDL stimulates myocardial perfusion in vivo (2005) (4)
Carboxyl terminus-truncated α1D-adrenoceptors inhibit the ERK pathway (2016) (4)
Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells (2020) (3)
Genetic Mosaicism in the Brain: A New Paradigm for Neuronal Diversity (2002) (3)
FISH analysis of human pluripotent stem cells. (2011) (3)
Spinal cord compression injury in lysophosphatidic acid 1 receptor‐null mice promotes maladaptive pronociceptive descending control (2016) (3)
GABAergic deficits in absence of LPA1 receptor, associated anxiety-like and coping behaviors, and amelioration by interneuron precursor transplants into the dorsal hippocampus (2021) (3)
LPA2 Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction (2022) (3)
Publisher Correction: Somatic APP gene recombination in Alzheimer’s disease and normal neurons (2019) (3)
Spectral Karyotyping and Fluorescent in situ Hybridization (2007) (3)
Lysophosphatidic acid3 receptor-mediated feed-forward production of lysophosphatidic acid : an initiator of nerve injury-induced neuropathic pain (2015) (3)
FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis (2022) (2)
Lysophosphatidic Acid Receptor 5 (LPA5) Knockout Ameliorates the Neuroinflammatory Response In Vivo and Modifies the Inflammatory and Metabolic Landscape of Primary Microglia In Vitro (2022) (2)
Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes (2017) (2)
Immunology. The sources of a lipid conundrum. (2007) (2)
Sphingosine 1-Phosphate Receptor 5 (S1P5) Knockout Ameliorates Adenine-Induced Nephropathy (2022) (2)
S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction (2022) (2)
Sepsis by using Cecal Ligation and Single Puncture Causes Alveolar Space Enlargement in LPA2 Knockout Mice (2012) (2)
Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiation. (2009) (2)
CAQK, a peptide associating with extracellular matrix components targets sites of demyelinating injuries (2022) (2)
The role of the lysophosphatidic acid (LPA) receptor 1 in developmental alveolarization (2013) (1)
S1P-5 Receptor (2008) (1)
Lysophosphatidic Acid Contributes to an Apoptosis Paradox in Lung Fibrosis. (2009) (1)
Lysophospholipid (S1P) receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
HeLa E-Box Binding Protein, HEB, Inhibits Promoter Activity of the Lysophosphatidic Acid Receptor Gene Lpar1 in Neocortical Neuroblast Cells (2019) (1)
Deletion of Lysophosphatidic acid Receptors 1 and 2 Protects Against Lipopolysaccharide‐Induced Acute Lung Injury in Mice (2010) (1)
Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding (2021) (1)
Human Genome & Diseases: Review Aneuploidy in the normal and diseased brain (2006) (1)
Lysophospholipid (LPA) receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
Targeted Deletion of LPA 5 Identifies Novel Roles for Lysophosphatidic Acid Signaling in Development of (2012) (1)
Prostaglandins and Other Lipid Mediators eview ysophosphatidic acid ( LPA ) receptors : Signaling properties and disease relevance (2010) (1)
S1P-1 Receptor (2008) (1)
Lysophosphatidic Acid and Sphingosine-1-Phosphate Activation of G-Protein-Coupled Receptors (2010) (1)
A Reply to Iourov et al. (2010) (1)
S1P-4 Receptor (2008) (1)
CHAPTER 22 – Recombination activating gene-1 (RAG-1) transcription in the mammalian CNS (1993) (1)
S1P-3 Receptor (2008) (1)
Lysophospholipid (LPA) receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database (2020) (1)
Deletion of Sphingosine 1-Phosphate Receptor 1 in cardiomyocytes during development leads to abnormal ventricular conduction and fibrosis (2020) (1)
An introduction to the Journal of Lipid Research Thematic Series on lysophospholipids (2014) (1)
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice (2022) (1)
Deletion of Sphingosine 1‐Phosphate receptor 1 in cardiomyocytes during development leads to abnormal ventricular conduction and fibrosis (2021) (1)
Author response: Genomic mosaicism with increased amyloid precursor protein (APP) gene copy number in single neurons from sporadic Alzheimer's disease brains (2015) (1)
Biological Effects of Naturally Occurring Sphingolipids, Uncommon Variants, and Their Analogs (2016) (0)
Involvement of E-protein, HEB, in transcriptional repression of the mouse lysophosphatidic acid receptor-1 gene expression in neocortical neuroblast cells (2009) (0)
Loss of LPA1 Signaling Protects Against Dermal Fibrosis in a Mouse Model of Systemic Sclerosis (2010) (0)
102 Sphingosine-1-phosphate triggers wound healing via the S1P2 receptor following acute liver injury (2006) (0)
LPA-2 Receptor (2008) (0)
Results Reduction in Autotaxin / Lysophospholipase D Levels Promotes Hypoxia-Induced Pulmonary Remodeling in Mice (2011) (0)
Generation of an Lpar1-EGFP Fusion Knock-in Transgenic Mouse Line (2021) (0)
Genomic Disorder and Gene Expression in the Developing CNS (2009) (0)
Activation of skeletal muscle FAPs by LPA requires the Hippo signaling via the FAK pathway. (2023) (0)
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis (2017) (0)
Flow Cytometric and Sorting Analyses for Nuclear DNA Content, Nucleotide Sequencing, and Interphase FISH (2017) (0)
Rapid communication Lysophosphatidic acid stimulates astrocyte proliferation through LPA1 (2008) (0)
Lysophospholipid GPCRs in medical therapeutics and disease mechanisms (2013) (0)
Lysophospholipid (LPA) receptors in GtoPdb v.2021.3 (2021) (0)
Somatic APP gene recombination in Alzheimer’s disease and normal neurons (2018) (0)
Lysophosphatidic Acid (LPA) Signaling in Neurogenesis (2017) (0)
Sphingosine 1-phosphate activates the MAP3K1-JNK pathway to promote epithelial movement and morphogenesis (2020) (0)
Th-P15:192 HDL and their constituent S1P acutely protect against myocardial infarction in vivo via the S1P3 sphingolipid receptor (2006) (0)
Correction to Supporting Information for Rohrback et al., Submegabase copy number variations arise during cerebral cortical neurogenesis as revealed by single-cell whole-genome sequencing (2018) (0)
ROLES FOR RECEPTOR-BASED LYSOPHOSPHATIDIC ACID SIGNALING IN THE DEVELOPING NERVOUS SYSTEM (1998) (0)
LPA-4 Receptor (2008) (0)
Sphingosine-1-phosphate triggers hepatic wound healing via the S1P2 receptor (2006) (0)
The limbic brain under stress: a role for the LPA1 receptor (2017) (0)
Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding (2021) (0)
Stress coping behaviour, brain connectivity and LPA1 receptor: similarities and differences between the genetic and the pharmacological approach (2018) (0)
THU0106 Lysophosphatidic Acid Receptor LPA1 is Essential for Development of Arthritis (2013) (0)
A Protocol Using Retrovirally Introduced Multiple Oncogenes for Producing Neuron-like Cell Lines from the Murine Central Nervous System (1993) (0)
Altered cleavage plane orientation with increased genomic aneuploidy produced by receptor-mediated lysophosphatidic acid (LPA) signaling in mouse cerebral cortical neural progenitor cells (2020) (0)
Targeting lysophospholipid S1P receptor for the treatment of multiple sclerosis (2010) (0)
SPHINGOSINE 1-PHOSPHATE ( S 1 P ) BIOLOGY AND ITS RELEVANCE TO MULTIPLE SCLEROSIS PATHOLOGY (2010) (0)
The type 1 lysophosphatidic acid receptor is involved in osteoblastogenesis up to osteocytogenesis (2020) (0)
LPA-5 Receptor (2008) (0)
CVR-2008-1173 R 4 S 1 P 3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species (2010) (0)
Abstract 424: Activation of the S1P3 Receptors is Responsible for S1P-mediated RhoA Activation and Cardioprotection (2015) (0)
Lysophospholipid ( S 1 P ) receptors ( version 2019 . 4 ) in the IUPHAR / BPS Guide to Pharmacology Database (2019) (0)
DEV121723 1390..1395 (2015) (0)
リゾホスファチジン酸受容体(LPA_3)の受精卵着床における役割 (2005) (0)
What role does the LPA1 receptor play in regulating emotional-like behaviours? (2015) (0)
Crystal Structure of Human Lysophosphatidic Acid Receptor 1 in complex with ONO-3080573 (2015) (0)
Series : Lysophospholipids and their Receptors LPA receptor signaling : pharmacology , physiology , and pathophysiology (0)
MECHANISM OF LYSOPHOSPHOLIPID RECEPTORSPECIFIC FUNCTION IN EMBRYO IMPLANTATION (2007) (0)
Reply (2011) (0)
Social avoidance and altered stress axis in a mouse model of anxious depression (2018) (0)
LPA-1 Receptor (2008) (0)
Lipid Signals: Extracellular (2008) (0)
Reduction but not absence of neuroblast apoptosis within the embryonic cortex of caspase 3-deficient mice (1999) (0)
S1P receptor localization confers selectivity for Gi mediated signaling pathways (2008) (0)
GABAergic precursor transplantation into the dorsal hippocampus of adult LPA1-null mice decreased anxiety-like behaviour (2013) (0)
Absence of LPA1 receptor results in altered pattern of limbic activation after tail suspension test (2016) (0)
Lysophospholipid S1P Receptors in Models of Multiple Sclerosis (2009) (0)
Carboxyl terminus-truncated α1D-adrenoceptors inhibit the ERK pathway (2016) (0)
Lysophosphatidic Acid Receptor Type 1 Plays a Crucial Role in Migration of Epithelial Cells in the Intestine (2011) (0)
Potential Biomarkers for Uterine Receptivity in LPA3-Deficient Females. (2009) (0)
and Christian vascular smooth muscle cells receptor-and non-receptor-mediated pathways in S 1 P activates store-operated calcium entry via (2011) (0)
mutation in the intestine MinApc tumorigenesis by The absence of LPA receptor 2 reduces the (2010) (0)
Cell biologic studies of the subplate during the development of the mammalian cerebral cortex (1988) (0)
Comparative cellular analysis of motor cortex in human, marmoset and mouse (2021) (0)
Inhibition of lymphocyte VLA-4 expression by DMF exposure in experimental autoimmune encephalomyelitis (EAE) (P2.188) (2015) (0)
Somatic genomic mosaicism in the brain: Identified mutations provide challenges and opportunities for the clinic. (2022) (0)
Publisher Correction: Somatic APP gene recombination in Alzheimer’s disease and normal neurons (2019) (0)
Lysophospholipid Receptor Signaling (2003) (0)
Sphingosine1-Phosphate(S1P)SignalingIsRequiredfor MaintenanceofHairCellsMainlyviaActivationofS1P 2 (2007) (0)
Abstract 404: Sphingosine-1-phosphate Receptor 1 Inhibits Pathological Cardiac Remodeling Through Histone Deacetylases (2018) (0)
Lysophospholipid (S1P) receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database (2020) (0)
A comparative strategy for single-nucleus and single-cell transcriptomes confirms accuracy in predicted cell-type expression from nuclear RNA (2017) (0)
Lysophosphatidic acid stimulates neuronal differentiation through LPA1 (2007) (0)
Extraction and Purification of Single Nuclei from Frozen Human Brain Tissue. (2023) (0)
Lysophospholipid (LPA) receptors in GtoPdb v.2021.2 (2021) (0)
Molecular mechanism of lysophosphatidic acid-induced hypertensive response (2019) (0)
Prolonged Exposure To S1P1 Agonists Worsens Vascular Leak, Fibrosis, And Mortality After Lung Injury (2010) (0)
Lysophosphatidic acid (LPA)-antibody (504B3) validation by free-solution assay and interferometry identifies off-target binding (2020) (0)
Author Correction: Comparative cellular analysis of motor cortex in human, marmoset and mouse (2022) (0)
Revealing the transcription factor regulatory context of human specific cortical development using single-cell multi-omics (2021) (0)
Lysophospholipid (S1P) receptors in GtoPdb v.2021.2 (2021) (0)
Title Loss of spinal substance P pain transmission under the condition of LPA 1 receptor-mediated neuropathic pain (2017) (0)
The absence of LPA1 receptor results in lipidome dysregulation and Neuropeptide-Y underexpression (2018) (0)
Growth plate modifications in lysophosphatidic acid LPA1 receptor-invalidated mice (2013) (0)
Pressure Lysophosphatidic Acid Receptors 1 and 2 Play Roles in Regulation of Vascular (2008) (0)
720 The Absence of LPA2 Attenuates Tumor Formation in Both An Animal Model of Colitis-Associated Cancer and APCMIN/+ Mice (2009) (0)
Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis (2023) (0)
Lysophosphatidic Acid Receptor-Specific Functions in Uterine Receptivity and Spermatogenesis. (2008) (0)
Role of the LPA1 receptor in mood and emotional regulation (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jerold Chun?

Jerold Chun is affiliated with the following schools:

Jerold Chun's Academic­Influence.com Rankings

Jerold Chun's Degrees

Why Is Jerold Chun Influential?

Jerold Chun's Published Works

Published Works

What Schools Are Affiliated With Jerold Chun?

Jerold Chun's AcademicInfluence.com Rankings